Showing results (161-170 of 281) with videos related to
Sort By:
Pageof 29
Journal of Biomedical Informatics|January 20, 2024
Strategies for secondary use of real-world clinical and administrative data for outcome ascertainment in pragmatic clinical trialsCynthia Hau, Patricia A Woods, Amanda S Guski, et al.Journal of Human Hypertension|February 27, 2019
Association of orthostatic hypertension with mortality in the Systolic Hypertension in the Elderly ProgramWilliam J Kostis, Davit Sargsyan, Choukri Mekkaoui, et al.Diabetes, Obesity & Metabolism|June 3, 2017
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutideHertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, et al.The American Journal of Cardiology|August 28, 2014
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)Omid Fatemi, Eugene Yuriditsky, Costas Tsioufis, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 27, 2024
36-month durability of ultrasound renal denervation for hypertension resistant to combination therapy in RADIANCE-HTN TRIOMichael J Bloch, Ajay J Kirtane, Michel Azizi, et al.JACC. Heart Failure|November 30, 2019
Heart Failure Prevention in Older Patients Using Intensive Blood Pressure Reduction: Potential Role of DiureticsBharathi Upadhya, Laura C Lovato, Michael Rocco, et al.American Journal of Hypertension|July 2, 2019
Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney EventsNaveen Rathi, Paul K Whelton, Glenn M Chertow, et al.Journal of the American Society of Hypertension : JASH|December 3, 2014
Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHATJosé-Miguel Yamal, Suzanne Oparil, Barry R Davis, et al.Lancet (London, England)|April 26, 2026
Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysisGuyu Zeng, Zeinab Bidel, Qianqian Yang, et al.JAMA Network Open|January 10, 2022
Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical TrialAlexander R Zheutlin, Favel L Mondesir, Catherine G Derington, et al.Pageof 29